文献速递心境障碍会诊联络精神医学

炎症与代谢失调同特定抑郁症状的关联:遗传相关与双样本孟德尔随机化研究

Dissecting the Association Between Inflammation, Metabolic Dysregulation, and Specific Depressive Symptoms: A Genetic Correlation and 2-Sample Mendelian Randomization Study.
PubMed 文献 · JAMA Psychiatry · 2021-01-01

该研究利用欧洲人群GWAS汇总数据,通过LDSC回归和双样本孟德尔随机化,探讨炎症活动、代谢失调与个体抑郁症状的遗传重叠及因果关联。结果显示CRP水平与抑郁症状存在遗传相关,IL-6信号上调与自杀倾向相关,较高BMI与快感缺失、疲劳、食欲改变及无用感相关,提示代谢失调可能因果影响特定抑郁症状。

要点

  • CRP水平与抑郁症状存在遗传相关,效应量与BMI和抑郁症状的遗传相关相似。
  • 遗传上调IL-6信号与自杀倾向相关,该结果在多种模型和敏感性分析中稳定。
  • 较高BMI与快感缺失、疲劳、食欲改变及无用感相关,提示代谢失调的潜在因果作用。

核心结论

  • CRP水平与个体抑郁症状存在共遗传性,可能源于代谢失调对快感缺失、疲劳、食欲改变及无用感的潜在因果关联。
  • IL-6信号与自杀倾向相关,提示抗炎尤其是IL-6阻断可能作为自杀预防的潜在策略。

研究设计与样本

  • 遗传相关与双样本孟德尔随机化研究,使用欧洲个体GWAS汇总数据。
  • 应用LDSC回归推断SNP基于遗传力和遗传相关,双样本MR检验CRP、IL-6信号及BMI遗传变异与抑郁症状的潜在因果关联。

主要发现

  • 遗传相关分析显示CRP水平与抑郁症状存在一致且经FDR控制的关联,遗传相关范围0.152-0.362,FDR P=.006至P<.001。
  • 双样本MR提示遗传上调IL-6信号与自杀倾向相关,估计值(SE)为0.035(0.010),FDR加Bonferroni校正P=.01。
  • MR分析未一致显示较高CRP水平或IL-6信号与其他抑郁症状相关。
  • 较高BMI与快感缺失、疲劳、食欲改变及无用感相关。

关键数值与推荐

  • CRP水平与抑郁症状的遗传相关范围0.152-0.362,FDR P=.006至P<.001。
  • IL-6信号与自杀倾向的MR估计值(SE)为0.035(0.010),FDR加Bonferroni校正P=.01。

临床怎么用

  • 提示抗炎方法尤其是IL-6阻断可能作为自杀预防的潜在策略。
  • 代谢失调可能因果影响快感缺失、疲劳、食欲改变及无用感,临床可关注代谢指标与这些症状的关联。

局限性

  • 研究基于欧洲个体GWAS汇总数据,结果外推至其他人群需谨慎。
  • 3项抑郁症状未区分方向相反的潜在症状(如失眠与嗜睡)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Observational studies highlight associations of C-reactive protein (CRP), a general marker of inflammation, and interleukin 6 (IL-6), a cytokine-stimulating CRP production, with individual depressive symptoms. However, it is unclear whether inflammatory activity is associated with individual depressive symptoms and to what extent metabolic dysregulation underlies the reported associations. OBJECTIVE: To explore the genetic overlap and associations between inflammatory activity, metabolic dysregulation, and individual depressive symptoms. GWAS DATA SOURCES: Genome-wide association study (GWAS) summary data of European individuals, including the following: CRP levels (204 402 individuals); 9 individual depressive symptoms (3 of which did not differentiate between underlying diametrically opposite symptoms [eg, insomnia and hypersomnia]) as measured with the Patient Health Questionnaire 9 (up to 117 907 individuals); summary statistics for major depression, including and excluding UK Biobank participants, resulting in sample sizes of 500 199 and up to 230 214 individuals, respectively; insomnia (up to 386 533 individuals); body mass index (BMI) (up to 322 154 individuals); and height (up to 253 280 individuals). DESIGN: In this genetic correlation and 2-sample mendelian randomization (MR) study, linkage disequilibrium score (LDSC) regression was applied to infer single-nucleotide variant-based heritability and genetic correlation estimates. Two-sample MR tested potential causal associations of genetic variants associated with CRP levels, IL-6 signaling, and BMI with depressive symptoms. The study dates were November 2019 to April 2020. RESULTS: Based on large GWAS data sources, genetic correlation analyses revealed consistent false discovery rate (FDR)-controlled associations (genetic correlation range, 0.152-0.362; FDR P = .006 to P < .001) between CRP levels and depressive symptoms that were similar in size to genetic correlations of BMI with depressive symptoms. Two-sample MR analyses suggested that genetic upregulation of IL-6 signaling was associated with suicidality (estimate [SE], 0.035 [0.010]; FDR plus Bonferroni correction P = .01), a finding that remained stable across statistical models and sensitivity analyses using alternative instrument selection strategies. Mendelian randomization analyses did not consistently show associations of higher CRP levels or IL-6 signaling with other depressive symptoms, but higher BMI was associated with anhedonia, tiredness, changes in appetite, and feelings of inadequacy. CONCLUSIONS AND RELEVANCE: This study reports coheritability between CRP levels and individual depressive symptoms, which may result from the potentially causal association of metabolic dysregulation with anhedonia, tiredness, changes in appetite, and feelings of inadequacy. The study also found that IL-6 signaling is associated with suicidality. These findings may have clinical implications, highlighting the potential of anti-inflammatory approaches, especially IL-6 blockade, as a putative strategy for suicide prevention.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Kappelmann N, Arloth J, Georgakis MK, et al. Dissecting the Association Between Inflammation, Metabolic Dysregulation, and Specific Depressive Symptoms: A Genetic Correlation and 2-Sample Mendelian Randomization Study. JAMA Psychiatry. 2021. PMID: 33079133. doi:10.1001/jamapsychiatry.2020.3436

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。